Tauvid™: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer’s Disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tauvid™: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer’s Disease
Authors
Keywords
-
Journal
Pharmaceuticals
Volume 14, Issue 2, Pages 110
Publisher
MDPI AG
Online
2021-01-30
DOI
10.3390/ph14020110
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration
- (2020) Elisabeth H. Thijssen et al. NATURE MEDICINE
- Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET
- (2020) Renaud La Joie et al. Science Translational Medicine
- Tau Positron Emission Tomographic Findings in a Former US Football Player With Pathologically Confirmed Chronic Traumatic Encephalopathy
- (2020) William G. Mantyh et al. JAMA Neurology
- Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes
- (2020) Adam S. Fleisher et al. JAMA Neurology
- Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders
- (2020) Antoine Leuzy et al. JAMA Neurology
- Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer’s disease
- (2020) Niklas Mattsson-Carlgren et al. Science Advances
- 18F-MK-6240 PET for early and late detection of neurofibrillary tangles
- (2020) Tharick A Pascoal et al. BRAIN
- Brain Tau Imaging - FDA Approval of Flortaucipir F18 Injection
- (2020) Venkata S. Mattay et al. JOURNAL OF NUCLEAR MEDICINE
- Amyloid-β and tau biomarkers and clinical phenotype in dementia with Lewy bodies
- (2020) Daniel Ferreira et al. NEUROLOGY
- Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease
- (2020) Shorena Janelidze et al. JAMA Neurology
- Tau PET imaging in neurodegenerative tauopathies—still a challenge
- (2019) Antoine Leuzy et al. MOLECULAR PSYCHIATRY
- Tau Imaging in Neurodegenerative Diseases Using Positron Emission Tomography
- (2019) Yi Ting Wang et al. Current Neurology and Neuroscience Reports
- Discovery and preclinical characterization of [18F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer’s disease and other tauopathies
- (2019) Heiko Kroth et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers
- (2019) Jinny Claire Lee et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Tau and atrophy: domain-specific relationships with cognition
- (2019) Leonardino A. Digma et al. Alzheimers Research & Therapy
- In vivo detection of cerebral tau pathology in long-term survivors of traumatic brain injury
- (2019) Nikos Gorgoraptis et al. Science Translational Medicine
- Head-to-head comparison of tau positron emission tomography tracers [18F]flortaucipir and [18F]RO948
- (2019) Ruben Smith et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Tau PET imaging with 18F-PI-2620 in patients with Alzheimer's disease and healthy controls: a first-in-human study
- (2019) Andre Mueller et al. JOURNAL OF NUCLEAR MEDICINE
- [18F]-AV-1451 binding profile in chronic traumatic encephalopathy: a postmortem case series
- (2019) Marta Marquié et al. Acta Neuropathologica Communications
- First-in-human brain imaging of Alzheimer dementia patients and elderly controls with18F-MK-6240, a PET tracer targeting neurofibrillary tangle pathology
- (2018) Talakad G Lohith et al. JOURNAL OF NUCLEAR MEDICINE
- Tau-targeting therapies for Alzheimer disease
- (2018) Erin E. Congdon et al. Nature Reviews Neurology
- Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807
- (2018) David T. Chien et al. JOURNAL OF ALZHEIMERS DISEASE
- Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F18]-T808
- (2018) David T. Chien et al. JOURNAL OF ALZHEIMERS DISEASE
- Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease
- (2018) Eric McDade et al. NEUROLOGY
- 18F-AV-1451 in Parkinson’s Disease with and without dementia and in Dementia with Lewy Bodies
- (2018) Ruben Smith et al. Scientific Reports
- MAO-B Inhibitors Do Not Block In Vivo Flortaucipir([18F]-AV-1451) Binding
- (2017) Allan K. Hansen et al. MOLECULAR IMAGING AND BIOLOGY
- The tau positron-emission tomography tracer AV-1451 binds with similar affinities to tau fibrils and monoamine oxidases
- (2017) Céline Vermeiren et al. MOVEMENT DISORDERS
- Amyloid-β and tau complexity — towards improved biomarkers and targeted therapies
- (2017) Juan Carlos Polanco et al. Nature Reviews Neurology
- Small-molecule PET Tracers for Imaging Proteinopathies
- (2017) Chester A. Mathis et al. SEMINARS IN NUCLEAR MEDICINE
- Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson’s case
- (2017) Marta Marquié et al. Acta Neuropathologica Communications
- [F-18]AV-1451 positron emission tomography retention in choroid plexus: More than “off-target” binding
- (2016) Milos D. Ikonomovic et al. ANNALS OF NEUROLOGY
- Synthesis and quality control of [18F]T807 for tau PET imaging
- (2016) Daniel P. Holt et al. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
- Pharmacokinetic Evaluation of the Tau PET Radiotracer 18 F-T807 ( 18 F-AV-1451) in Human Subjects
- (2016) Dustin W. Wooten et al. JOURNAL OF NUCLEAR MEDICINE
- Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles
- (2016) E. D. Hostetler et al. JOURNAL OF NUCLEAR MEDICINE
- Human Radiation Dosimetry of [18F]AV-1451(T807) to Detect Tau Pathology
- (2016) Jae Yong Choi et al. MOLECULAR IMAGING AND BIOLOGY
- PET Imaging of Tau Deposition in the Aging Human Brain
- (2016) Michael Schöll et al. NEURON
- Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease
- (2016) Matthew R. Brier et al. Science Translational Medicine
- An autoradiographic evaluation of AV-1451 Tau PET in dementia
- (2016) Val J. Lowe et al. Acta Neuropathologica Communications
- Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue
- (2015) Marta Marquié et al. ANNALS OF NEUROLOGY
- Tau in physiology and pathology
- (2015) Yipeng Wang et al. NATURE REVIEWS NEUROSCIENCE
- A Philosophy for CNS Radiotracer Design
- (2014) Genevieve C. Van de Bittner et al. ACCOUNTS OF CHEMICAL RESEARCH
- Fluorine-18 Radiochemistry, Labeling Strategies and Synthetic Routes
- (2014) Orit Jacobson et al. BIOCONJUGATE CHEMISTRY
- Radiosynthesis, Photoisomerization, Biodistribution, and Metabolite Analysis of 11C-PBB3 as a Clinically Useful PET Probe for Imaging of Tau Pathology
- (2014) H. Hashimoto et al. JOURNAL OF NUCLEAR MEDICINE
- [18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease
- (2013) Chun-Fang Xia et al. Alzheimers & Dementia
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- (2013) Clifford R Jack et al. LANCET NEUROLOGY
- National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
- (2012) Bradley T. Hyman et al. Alzheimers & Dementia
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
- (2009) Clifford R Jack et al. LANCET NEUROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now